Caribou Biosciences, Inc. (CRBU) Social Stream



Caribou Biosciences, Inc. (CRBU): $7.60

-0.18 (-2.31%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Add CRBU to Watchlist
Sign Up

Industry: Biotech


Ranked

of 401

in industry

CARIBOU BIOSCIENCES INC (CRBU) Price Targets From Analysts

The tables below show price targets and recommendations from analysts covering CARIBOU BIOSCIENCES INC.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-11-12 3 $33 $27 $30.666 $7.29 320.66%
2021-11-15 3 $33 $27 $30.666 $7.29 320.66%
2021-11-30 5 $33 $27 $30 $7.29 311.52%
2022-01-28 5 $36 $27 $31.2 $7.29 327.98%
2022-02-14 6 $36 $19 $29.166 $7.29 300.08%
2022-03-21 7 $36 $19 $28.142 $7.29 286.04%
2022-05-09 7 $36 $19 $27 $7.29 270.37%
2022-08-10 7 $39 $19 $29.428 $7.29 303.68%
2022-08-13 7 $39 $19 $29 $7.29 297.81%
2022-08-18 7 $39 $19 $28.857 $7.29 295.84%
2022-11-08 7 $38 $19 $28.714 $7.29 293.88%
2022-12-12 7 $38 $19 $28.571 $7.29 291.92%
2023-01-26 7 $38 $19 $29.285 $7.29 301.71%

The Trend in the Analyst Price Target


CRBU's average price target has moved down $0.14 over the prior 36 weeks.

CRBU reports an average of 223.9% for its upside potential over the past 49 weeks.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2022-03-21 7 36 19 27.714 9.15 202.89%
2022-03-21 7 36 19 28.142 9.15 207.56%
2022-05-09 7 36 19 27.142 6.67 306.93%
2022-08-18 7 39 19 28.857 10.33 179.35%
2023-01-26 7 38 19 29.285 6.94 321.97%

CRBU Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1.14 6 1 0 0 0 7

The Trend in the Broker Recommendations


Over the past 92 days, CRBU's average broker recommendation rating improved by 0.

The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for CRBU as an investment opportunity.

  • To contextualize these metrics, consider that out of all US stocks, CARIBOU BIOSCIENCES INC's upside potential (average analyst target price relative to current price) is higher than 1529.7% of them.
  • CRBU has a lower variance in analysts' estimates than -868.76% of all US stocks.
  • CRBU has a higher number of analysts covering the stock than 1273.88% of stocks in the small market cap category.
  • CRBU has a greater average analyst price target than 1205.36% of stocks in the small market cap category.

Stocks similar to CARIBOU BIOSCIENCES INC in the Pharmaceutical Products industry regarding analyst recommendations and price targets are FUSN, PSTX, and ITOS.

Make investment decisions regarding CRBU using the data that counts. Try POWR Ratings for free.


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.5733 seconds.